North America
North America holds a substantial share in the global Ebstein’s Anomaly market due to advanced healthcare infrastructure, increased awareness about rare congenital heart diseases, and early diagnosis. The United States leads the region, driven by extensive research in pediatric cardiology and the availability of specialized healthcare facilities. The rising prevalence of...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian